Neuralink Begins First Human Trial of Brain-Computer Interface Implant

Elon Musk's Neuralink has initiated its first human trial with the brain chip implant Telepathy, aiming to enable control of devices through thought.

The first human trial of Neuralink’s brain-computer interface implant, named Telepathy, has started, following FDA approval in 2023.
The implant aims to allow individuals with severe physical disabilities to control digital devices using their thoughts.
Neuralink’s mission extends beyond medical aids to enhancing human cognitive and sensory capabilities in the long run.
The technology faces challenges including societal, ethical, and technological implications.
Widespread acceptance of Neuralink’s technology will depend on its medical efficacy, safety, and ability to address ethical concerns.